ANEXO I FICHA TÉCNICA O RESUMEN DE LAS …
2 1. NOMBRE DEL MEDICAMENTO Prevenar 13 suspensión inyectable Vacuna antineumocócica polisacárida conjugada (13-valente, adsorbida) 2. COMPOSICIÓN CUALITATIVA Y CUANTITATIVA
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
FACHINFORMATION (ZUSAMMENFASSUNG DER …
www.impfkritik.deInfektion, Krebserkrankung, hämatopoeti-sche Stammzelltransplantation, nephroti-sches Syndrom) sind keine Daten zur Si-cherheit und Immunogenität für Prevenar13
IMMUNISATION SCHEDULE ACKERMANS PRIVATE …
www.ackermanspharmacy.co.zaimmunisation schedule ackermans private clinic . epi schedule : additional private (supplied by state) vaccines :
Private, Schedule, Clinic, Immunisation, Ackerman, Immunisation schedule ackermans private, Immunisation schedule ackermans private clinic
This book belongs to - CYH
www.cyh.compage 2 Welcome to your child’s health and development record How to use this record Use it to check and record your child’s: > health and development
Immunisation - CYH
www.cyh.compage 11 Immunisation What is immunisation and why does my child need it? Immunisation is a simple, safe and effective way to protect children (and adults) from serious diseases.
INFANRIX hexa New Zealand Datasheet - Medsafe
www.medsafe.govt.nz1 INFANRIX hexa New Zealand Datasheet . INFANRIX hexa is a combined diphtheria-tetanus-acellular pertussis, hepatitis B, enhanced inactivated polio vaccine and Haemophilus influenzae type b vaccine.
Datasheet, Zealand, Infanrix, Exha, Infanrix hexa new zealand datasheet
National Immunisation Program Schedule …
www.ncirs.edu.auNational Immunisation Program Schedule Queensland Age Vaccine Disease Routine childhood vaccinations plus additional vaccines for: Aboriginal & …
Programs, Schedule, National, Queensland, Immunisation, National immunisation program schedule, National immunisation program schedule queensland
WHO PACKAGE INSERT
www.who.intSynflorix™ Page 4 of 9 WHO Package insert (Final) For children at high-risk for pneumococcal disease (such as children with sickle cell disease, asplenia,